|Bid||7.44 x 0|
|Ask||7.46 x 0|
|Day's Range||7.30 - 7.68|
|52 Week Range||5.29 - 16.24|
|Beta (3Y Monthly)||1.15|
|PE Ratio (TTM)||25.92|
|Earnings Date||Feb 27, 2019 - Mar 4, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.75|
Will marijuana stocks implode in 2019? Will the farm bill be a major catalyst? Here's a 2019 outlook for what to expect from the marijuana industry.
Earlier on December 18, Tilray (TLRY) announced a supply deal with Novartis—one of the largest global drug makers. Tilray stock rose nearly 11% following the announcement. Novartis stock was trading ~1.3% lower on in the European market.
The cannabis industry has seen highs and lows in 2018. Before we do that, let’s recap what happened to the four developments listed in our previous series from June, Top Four Developments We’re Watching in the Cannabis Sector. In the second half of 2018, the cannabis sector remained busy getting cannabis products from production to customers.
In the earlier part of this series, we looked at how Canopy Growth (WEED) is testing hemp-based CBD products to lower anxiety in dogs. While talking about the different uses of hemp-based CBD in its Q2 2019 earnings call, Canopy Growth said that it could develop anti-inflammatory products such as sports drinks for the US market. Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.
With the demand for hemp growing by leaps and bounds, could it be time to take another look at pot stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC)?
The latest developments in the US, particularly the ones surrounding the Farm Bill, have been encouraging to the cannabis industry in the US. One of the most important changes that cannabis companies have been waiting for is legislation on hemp farming. On December 12, the Senate passed the Farm Bill, which will have a term of five years. The bill makes hemp a legal agricultural commodity, which would allow cannabis companies a legal foray into the US cannabis market.
Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) made another big splash in December. Its stock will need to double up to get back to all-time highs over the next year.
Four backup credit cards were hidden underneath the counter of the St. John’s, N.L. pot shop at the stroke of midnight on legalization day, according to Bruce Linton, the ceremonial salesperson who rang up Canada’s first gram of recreational cannabis on Oct. 18.
HENDERSON, NV / ACCESSWIRE /December 14, 2018 / The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13. The next move is that the legislation heads to the House for a vote - and then ...
CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / The United States Senate and House passed the 2018 Farm Bill this week thus paving the way for CBD and hemp legalization. Hemp products are made in America, sold in America, and consumed in America.
On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec. The agreement between Tilray’s subsidiary High Park Farms and ROSE LifeScience entails an exclusive sale, distribution, supply, and marketing agreement. Tilray will spend 7.5 million Canadian dollars, which accounts for 12% in capital for ROSE LifeScience.
For a long time, we’ve discussed how product differentiation will be key to the success of cannabis producers (HMMJ) in such a crowded market. Companies within the cannabis space know this very well and are making early moves to develop and acquire intellectual property rights from other companies to be able to develop unique products that may someday be a blockbuster for the companies. On December 3, Canopy Growth (WEED) announced a multiyear agreement with Valens GroWorks (MYMSF).
After the significant decline in Aphria’s (APHA) value last week, the company provided some respite to investors by purchasing shares worth $3.1 million. The company announced a special committee that consists of independent directors who will review the allegations that led Aphria’s downfall. On December 13, Aphria stock fell ~9.5% to 7.04 Canadian dollars.
International markets are becoming more important for cannabis companies (MJ). Tilray (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), and Cronos Group (CRON) each have international operations, as you can see in the following chart.
On December 11, we reported that the farm bill is expected to be voted on later this week. The farm bill contained a lot of important changes. One of the most important changes that cannabis enthusiasts have been waiting for is the legislation on hemp farming. On December 12, the Senate passed the farm bill, which will have a term of five years.
Following Altria’s news, Cronos Group (CRON) received target price upgrades from notable investment management companies. On average, four companies (MJ) upgraded Cronos Group’s target price by nearly 70%.
EDMONTON — Aurora Cannabis Inc. has signed a deal to invest $10 million in High Tide Inc., a privately held company with cannabis and cannabis accessory retail stores.
Participating in a Rapidly Growing Cannabis and Lifestyle Accessories Retailer TSX | NYSE: ACB EDMONTON , Dec. 13, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ...
/THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES ...
Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) continues to expand its reach around the world, but is it necessary?